KR900018033A - 나프탈렌프로피온산 염 - Google Patents

나프탈렌프로피온산 염 Download PDF

Info

Publication number
KR900018033A
KR900018033A KR1019890016130A KR890016130A KR900018033A KR 900018033 A KR900018033 A KR 900018033A KR 1019890016130 A KR1019890016130 A KR 1019890016130A KR 890016130 A KR890016130 A KR 890016130A KR 900018033 A KR900018033 A KR 900018033A
Authority
KR
South Korea
Prior art keywords
carbon atoms
amine
hydroxyalkyl
hydrogen
compound
Prior art date
Application number
KR1019890016130A
Other languages
English (en)
Inventor
프랭크 크레프트 3세 안토니
헨리 머서 존
제이콥 빅슬러 제임즈
윌리암 지버슨 존
마틴 쿠브랙 데니스
Original Assignee
에건 이. 베르그
아메리칸 홈 프로덕츠 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에건 이. 베르그, 아메리칸 홈 프로덕츠 코포레이션 filed Critical 에건 이. 베르그
Publication of KR900018033A publication Critical patent/KR900018033A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

나프탈렌프로피온산 염
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. α-메틸-6-(2-퀴놀리닐메톡시)-2-나프탈렌아세트산, 아민 염[여기서, 아민은 일반식 NR1R2R3(여기서, R1은 수소, 페닐, 탄소수 1 내지 6의 알킬 또는 탄소수 1 내지 6의 하이드록시알킬이고, R2는 수소, 탄소수 1 내지 6의 하이드록시알킬이며, R3은 탄소수 1 내지 12의 하이드록시알킬이다)의 하이드록시알킬아민이다).
  2. S(+)-α-메틸-6-(2-퀴놀리닐메톡시)-2-나프탈렌 아세트산, 아민 염[여기서, 아민은 제1항에서 정의한 바와 같은 일반식 NR1R2R3의 하이드록시알킬아민이다).
  3. R(-)-α-메틸-6-(2-퀴놀리닐메톡시)-2-나프탈렌 아세트산, 아민 염[여기서, 아민은 제1항에서 정의한 바와 같은 일반식 NR1R2R3의 하이드록시알킬아민이다).
  4. 제1항 내지 3항중 어느 한 항에 있어서, R1및 R2가 1개 내지 3개의 탄소원자를 갖는 알킬 또는 하이드록시알킬 그룹이고, R3이 1개 내지 6개의 탄소원자를 갖는 하이드록시알킬 그룹인 화합물.
  5. 제1항 내지 4항중 어느 한 항에 있어서, 그룹R3이 폴리하이드록시 알킬 그룹인 화합물.
  6. 제1항 내지 3항중 어느 한항에 있어서, R1및 R2가 수소인 화합물.
  7. 제6항에 있어서, 아민이 트로메트아민인 화합물.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019890016130A 1989-05-12 1989-11-08 나프탈렌프로피온산 염 KR900018033A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US351,119 1989-05-12
US07/351,119 US4960892A (en) 1988-06-10 1989-05-12 Naphthalenepropionic acid derivatives as anti-inflammatory/anti-allergic agents

Publications (1)

Publication Number Publication Date
KR900018033A true KR900018033A (ko) 1990-12-20

Family

ID=23379653

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890016130A KR900018033A (ko) 1989-05-12 1989-11-08 나프탈렌프로피온산 염

Country Status (15)

Country Link
US (1) US4960892A (ko)
EP (1) EP0396839B1 (ko)
JP (1) JPH02311463A (ko)
KR (1) KR900018033A (ko)
AT (1) ATE104281T1 (ko)
AU (1) AU629868B2 (ko)
CA (1) CA1331001C (ko)
DE (1) DE68914646T2 (ko)
DK (1) DK169545B1 (ko)
ES (1) ES2063143T3 (ko)
GB (1) GB2231570B (ko)
IE (1) IE61967B1 (ko)
IL (1) IL92083A0 (ko)
NZ (1) NZ231255A (ko)
ZA (1) ZA898291B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
US5208344A (en) * 1987-07-31 1993-05-04 American Home Products Corporation Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
ES2058024B1 (es) * 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
ES2124196B1 (es) * 1997-06-04 1999-12-01 Menarini Lab Procedimiento para la fabricacion de una forma farmaceutica semisolida conteniendo dexketoprofeno trometamol y su utilizacion en el tratamiento topico de la inflamacion.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
DE2134672A1 (de) * 1971-07-08 1973-01-25 Josef Dipl Chem Dr Rer N Klosa Wasserloesliches acetylsalicylsaeuresalz, dessen herstellung, zubereitung und anwendung
US4097674A (en) * 1975-03-17 1978-06-27 Syntex Corporation 2-Naphthylacetic acid derivatives
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4754043A (en) * 1985-10-03 1988-06-28 American Home Products Corporation Oxazole and thiazole naphthalenes as antiallergic agents
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
AU611699B2 (en) * 1987-07-31 1991-06-20 American Home Products Corporation Naphthalene propionic acid derivatives
IL133435A0 (en) * 1997-06-12 2001-04-30 Northrop Grumman Corp Heat resistant composite structure

Also Published As

Publication number Publication date
EP0396839A3 (en) 1991-06-05
EP0396839B1 (en) 1994-04-13
JPH02311463A (ja) 1990-12-27
DK117590A (da) 1990-11-13
DK169545B1 (da) 1994-11-28
IE893519L (en) 1990-11-12
IL92083A0 (en) 1990-07-12
CA1331001C (en) 1994-07-26
DE68914646D1 (de) 1994-05-19
DE68914646T2 (de) 1994-07-21
ZA898291B (en) 1991-06-26
US4960892A (en) 1990-10-02
GB2231570B (en) 1992-05-20
AU4436189A (en) 1990-11-15
NZ231255A (en) 1991-02-26
ATE104281T1 (de) 1994-04-15
GB2231570A (en) 1990-11-21
EP0396839A2 (en) 1990-11-14
ES2063143T3 (es) 1995-01-01
DK117590D0 (da) 1990-05-10
GB8924501D0 (en) 1989-12-20
IE61967B1 (en) 1994-11-30
AU629868B2 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
PT92752A (pt) Processo para a preparacao de benzilideno-azolilmetilcicloalcanos ou alcenos e de composicoes fungicidas que os contem
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR930702254A (ko) 아닐리드 유도체
PT95092A (pt) Processo para a preparacao enantiosselectiva de derivados da fenil-iso-serina e de preparacao da bacatina iii ou da 10-desacetilbacatina iii a partir daqueles derivados
KR950011444A (ko) 갈란타민 유도체, 이의 제조방법 및 약제로서의 이의 용도
KR900018033A (ko) 나프탈렌프로피온산 염
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR900001673A (ko) N-치환 아미드 유도체
KR920007995A (ko) 벤즈아미드 유도체
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
KR870004992A (ko) 세팔로스포린 유도체의 제조방법
KR930702339A (ko) 에폭시숙시남산 유도체
KR850005228A (ko) 살균제인 아미노알칸포스폰산 및 그 유도체
KR900701779A (ko) 옥시란유도체 및 그것을 유효성분으로 하는 제초제
KR900018083A (ko) 에폭시숙신산 유도체
ATE325101T1 (de) Hexahydroindenopyridinverbindungen mit antispermatogener aktivität
KR970006283A (ko) 신규 아민고리 화합물
KR910000715A (ko) 3-데옥시 마이카미노실틸로놀리드 유도체
KR920002613A (ko) 이환성 함유 황화합물
KR830001265A (ko) 새로운 티아디아졸 화합물류와 그 제조방법
KR930000528A (ko) 아미노피롤리딘 백금화합물 및 그 제조방법
KR840008160A (ko) 신규 세팜 화합물 및 그의 제조방법
KR890009944A (ko) 세팔로스포린 유도체
KR830002718A (ko) 피라졸 유도체의 제조법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid